Mark E Mossberg

Title: **Mark E. Mossberg: Innovator in Intraocular Lens Technology**

Introduction

Mark E. Mossberg, hailing from Santa Ana, California, is a prominent inventor in the field of ophthalmic technology. With a focus on enhancing surgical procedures, he has developed innovative solutions that improve the delivery of intraocular lenses (IOL) during cataract surgeries.

Latest Patents

Mark holds a noteworthy patent titled "Injector assembly employing compressed gas and a mechanical brake for presenting an intraocular lens to a patient." This invention is designed for single-hand operation and utilizes compressed gas to provide the motive force necessary for introducing the IOL to the surgical site. The injector includes a mechanical brake that prevents the translation of an IOL without operator intervention. This feature allows for the selective adjustment of speed and translation, ensuring precise control when presenting the IOL to patients. Additionally, the injector is equipped with a first stop to halt the movement of the plunger at a predetermined position, which can be adjusted for further operator-controlled translation.

Career Highlights

Mark is affiliated with Bausch & Lomb Incorporated, a leading company in eye health and vision care. His work there has contributed significantly to advancements in surgical technologies aimed at improving patient outcomes and enhancing the efficiency of ophthalmic procedures.

Collaborations

Throughout his career, Mark has collaborated with talented colleagues such as Sushant P. Muchhala and Moises A. Valle. These partnerships have been instrumental in driving innovation and fostering the development of cutting-edge solutions in the medical field.

Conclusion

Mark E. Mossberg exemplifies the spirit of innovation in medical technology. His patent for an IOL injector not only showcases his inventive capabilities but also highlights the importance of precision and control in surgical operations. As he continues his work at Bausch & Lomb Incorporated, the contributions of Mark and his colleagues will undoubtedly shape the future of ophthalmic procedures, improving the lives of many patients.